# OnCo record nct03246529 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct03246529/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct03246529", "NCT03246529" ;
  schema:name "A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and Granulocyte Colony Stimulating Factor (G-CSF) as Compared to Pl"@en ;
  schema:alternateName "GENESIS"@en ;
  schema:description "A phase 3 trial of Filgrastim in multiple myeloma, run by BioLineRx, Ltd., active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct03246529/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03246529> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2018-03-23" ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:technologies <https://onco.cc/technologies/g-csf-growth-factors/> ;
  onco:drugs <https://onco.cc/drugs/filgrastim/> ;
  onco:companies <https://onco.cc/companies/biolinerx/> .